Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 June 2020 | Story Leonie Bolleurs | Photo Supplied
Prof Zakkie Pretorius, left, plays a significant role in providing pathology support to the plant breeding industry.Prof Liezel Herselman contributes to plant breeding in Southern Africa by training and mentoring the plant breeders of the future.

The Southern African Plant Breeders’ Association (SAPBA) recently bestowed prestigious awards upon Prof Zakkie Pretorius, Research Fellow in the Department of Plant Sciences at the University of the Free State (UFS), and Prof Liezel Herselman, Associate Professor in the same department. This institution strives to maintain high ethical standards and norms, contributing to stable, sustainable agriculture.

During the 13th Southern African Plant Breeders’ Association symposium, Prof Herselman was presented with a Fellow Award and Prof Pretorius with Honorary Membership. They received the awards for their services to and promotion of the SAPBA objectives, together with their exceptional contributions to plant breeding. 

Provide food for the nation
Over the years, Prof Pretorius, who has extensive expertise in diseases of field crops – more specifically the rust diseases of small grain cereal crops – has played a significant role in providing pathology support to the plant breeding industry. He has also conducted ground-breaking pathology research on rust diseases in field crops. In 2019, he co-authored an article that appeared in Nature, the world’s leading multidisciplinary science journal. He is also shortlisted as a 2020 finalist in the Lifetime Award and Special Theme Award (Plant Health) of the National Science and Technology Forum. Furthermore, he regularly attended and participated in biennial conferences and supervised plant breeding students working on plant disease projects. 

Prof Herselman contributes to plant breeding in Southern Africa by training and mentoring the plant breeders of the future. “As a lecturer of fourth-year and honours Plant Breeding students, as well as supervisor and promoter of master’s and doctoral students, I am in the fortunate position to teach and mentor my students in one of the newest fields of plant breeding, namely marker-assisted plant breeding. All future plant breeders need this knowledge to make a success of their breeding programmes. Our students are the future plant breeders who will provide food to the nation,” she says. 

"As a plant pathologist, I am privileged to have been able to contribute to the quest for disease resistance in crop improvement and to have been recognised for it.” – Prof Zakkie Pretorius
The highest honour
Prof Pretorius view recognition by the industry – in this case, the plant breeding fraternity – as the highest honour for someone working in agricultural science. “As a plant pathologist, I am privileged to have been able to contribute to the quest for disease resistance in crop improvement and to have been recognised for it. I am also extremely grateful to colleagues and co-workers who have contributed over many years to the establishment of a productive and influential research group at the UFS,” he says.

Prof Herselman shares this sentiment. She says: “It means so much to me to know that I have made a difference and an impact on my students’ lives. It is a privilege to have the opportunity to work with under- and postgraduate students and to see them grow.”

She continues: “We strive to send out well-rounded students who can make a difference in the workplace and the community. This award means that I have succeeded in this goal, even though I do my work because I am passionate about it and not to receive recognition.”

Fight against fungal disease continues
Prof Pretorius continues to be involved in studies on host plant resistance and pathogenic variability. 

As a molecular plant breeder, Prof Herselman is pushing on with research focusing on the development of wheat lines with improved disease resistance. The work that she is doing makes a difference on both national and international level. “As part of my current research programme, we have made rust- and Fusarium head blight-resistant wheat lines available to South African breeding companies for use in their breeding programmes. The lines developed at the UFS will in a small way contribute towards the fight against fungal diseases in South Africa, thus securing the yield and livelihoods of farmers and consumers,” she says.

Her master’s and doctoral students who have completed their studies, also take the knowledge they gained at the UFS back to their countries and workplaces where they ultimately add value, especially contributing towards the fight against hunger. 

"“We strive to send out well-rounded students who can make a difference in the workplace and the community. This award means that I have succeeded in this goal, even though I do my work because I am passionate about it and not to receive recognition.” – Prof Liezel Herselman

News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept